In re: Zyprexa Prods. Liab. Litig., No. 07-3815
In a drug defect product liability litigation, appellant-law firm's interlocutory appeal from the district court's order finding that all of appellant-law firm's cases that were pending in the district court were subject to certain attorney compensation strictures and that appellant was prohibited from making any disbursements from a fund that it maintained until a fund administrator had certified that the protocols had been adhered to, is dismissed where the injunction did not give or aid in giving substantive relief sought in the lawsuit, and thus there was no jurisdiction under 28 U.S.C. section 1292(a).
Read In re: Zyprexa Prods. Liab. Litig., No. 07-3815
Argued: March 12, 2009
Final Submission: June 17, 2009
Robert J. Lack, Friedman Kaplan Seiler & Adelman LLP, New York, NY
Eric Roberson, The Mulligan Law Firm, Dallas, TX
William M. Audet, Audet & Partners, LLP, San Francisco, CA
James M. Shaughnessy, Milberg LLP, New York, NY
You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help
Meeting with a lawyer can help you understand your options and how to best protect your rights. Visit our attorney directory to find a lawyer near you who can help.